Posts

Championing women’s brain health

A new review from the Women’s Brain Foundation, with involvement from the team at Scottish Brain Sciences, suggests that women’s higher risk of dementia may be linked to estrogen.

Accelerating Alzheimer’s Research webinar: Insights for professionals supporting people living with Alzheimer’s

We are sharing the latest updates on clinical trials, new treatment pathways, and the role of cognitive sciences in early detection and prevention.

Our Edinburgh research centre is moving!

We are delighted to share that we are moving our Edinburgh base and headquarters to a newly refurbished research facility within Scottish Gas Murrayfield stadium.

Lecanemab is approved by MHRA in Great Britain, and restricted in NHS

Following today’s announcements from the MHRA and NICE about a new drug, lecanemab – which approve its use in Great Britain, but block its adoption in NHS England – our CEO and Founder, Prof Craig Ritchie has responded.

New Alzheimer’s Vaccine Trial in Scotland

Scottish Brain Sciences is delighted to be the first clinical site open in the UK & Europe, to deliver a clinical trial of a new active immunotherapy (a vaccine) aimed at preventing or slowing the progression of Alzheimer’s Disease.

Blood biomarkers can reveal Alzheimer disease progression, study finds

New blood tests for a protein linked with Alzheimer’s Disease can identify those patients whose disease is progressing.

Analysis Begins on Blood Samples for Markers of Alzheimer’s Disease

Researchers working in the Scottish Brain Sciences (SBS) Biomarker Laboratory have begun to analyse blood samples for markers of Alzheimer’s disease.

Can we Prevent and Cure Alzheimer’s Disease?

The fantastic speaker sessions from our first Open Research event are now available to watch on our YouTube channel

Stress Awareness Month at Scottish Brain Sciences

April is Stress Awareness Month, and the theme for 2024 is “Little by Little,” so let’s take a closer look…